PL327037A1 - Novel combination - Google Patents

Novel combination

Info

Publication number: PL327037A1
Authority: PL; Poland
Prior art keywords: novel combination; novel; combination
Prior art date: 1996-10-08

Application number

PL97327037A

Inventor

Jan Trofast

Anders Ullman

Original Assignee

Astra Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-08

Filing date

1997-09-24

Publication date

1998-11-09

1997-09-24 Application filed by Astra Ab filed Critical Astra Ab

1998-11-09 Publication of PL327037A1 publication Critical patent/PL327037A1/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Plant Substances (AREA)
Medicinal Preparation (AREA)

PL97327037A 1996-10-08 1997-09-24 Novel combination PL327037A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9603669A SE9603669D0 (en)	1996-10-08	1996-10-08	New combination
PCT/SE1997/001606 WO1998015280A1 (en)	1996-10-08	1997-09-24	New combination

Publications (1)

Publication Number	Publication Date
PL327037A1 true PL327037A1 (en)	1998-11-09

Family

ID=20404167

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL97327037A PL327037A1 (en)	1996-10-08	1997-09-24	Novel combination

Country Status (18)

Country	Link
EP (1)	EP0871450A1 (en)
JP (1)	JP2000502365A (en)
KR (1)	KR19990071975A (en)
AR (1)	AR013614A1 (en)
AU (1)	AU715319B2 (en)
BR (1)	BR9706822A (en)
CA (1)	CA2239308A1 (en)
CZ (1)	CZ176198A3 (en)
HU (1)	HUP9901674A3 (en)
MY (1)	MY128337A (en)
NO (1)	NO982414D0 (en)
NZ (1)	NZ330482A (en)
PL (1)	PL327037A1 (en)
SE (1)	SE9603669D0 (en)
SK (1)	SK75198A3 (en)
TW (1)	TW470647B (en)
WO (1)	WO1998015280A1 (en)
ZA (1)	ZA978889B (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5983956A (en)	1994-10-03	1999-11-16	Astra Aktiebolag	Formulation for inhalation
US5980949A (en) *	1994-10-03	1999-11-09	Astra Aktiebolag	Formulation for inhalation
SE9700134D0 (en) *	1997-01-20	1997-01-20	Astra Ab	New formulation
SE9700136D0 (en) *	1997-01-20	1997-01-20	Astra Ab	New formulation
SE9700135D0 (en) *	1997-01-20	1997-01-20	Astra Ab	New formulation
SE9700133D0 (en) *	1997-01-20	1997-01-20	Astra Ab	New formulation
SK184799A3 (en) *	1997-06-27	2000-06-12	Astra Ab	New combination of antiasthma medicaments
SE9703407D0 (en)	1997-09-19	1997-09-19	Astra Ab	New use
SE9802073D0 (en)	1998-06-11	1998-06-11	Astra Ab	New use
US6451285B2 (en)	1998-06-19	2002-09-17	Baker Norton Pharmaceuticals, Inc.	Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6004537A (en) *	1998-12-18	1999-12-21	Baker Norton Pharmaceuticals, Inc.	Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
US6290930B1 (en)	1998-12-18	2001-09-18	Baker Norton Pharmaceuticals, Inc.	Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
SE9900834D0 (en) *	1999-03-09	1999-03-09	Astra Ab	Novel combination
DE19921693A1 (en) *	1999-05-12	2000-11-16	Boehringer Ingelheim Pharma	Pharmaceutical composition for treating respiratory disorders, e.g. asthma, comprises combination of anticholinergic and beta-mimetic agents having synergistic bronchospasmolytic activity and reduced side-effects
ES2165768B1 (en)	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
GB0009584D0 (en) *	2000-04-18	2000-06-07	Glaxo Group Ltd	Pharmaceutical compositions
GB0012260D0 (en) *	2000-05-19	2000-07-12	Astrazeneca Ab	Novel composition
FI20002216A0 (en)	2000-10-06	2000-10-06	Orion Yhtymae Oyj	Combination particles for asthma therapy
US6667344B2 (en)	2001-04-17	2003-12-23	Dey, L.P.	Bronchodilating compositions and methods
US20030055026A1 (en)	2001-04-17	2003-03-20	Dey L.P.	Formoterol/steroid bronchodilating compositions and methods of use thereof
SE0200312D0 (en)	2002-02-01	2002-02-01	Astrazeneca Ab	Novel composition
SE527069C2 (en)	2003-06-19	2005-12-13	Mederio Ag	Method and apparatus for administering drug powder
TWI359675B (en)	2003-07-10	2012-03-11	Dey L P	Bronchodilating β-agonist compositions
US20050026887A1 (en) *	2003-07-29	2005-02-03	Boehringer Ingelheim International Gmbh	Medicaments for inhalation comprising an anticholinergic and a steroid
JP5508003B2 (en)	2006-06-30	2014-05-28	アイスイティカピーティーワイリミテッド	Process for the preparation of biologically active compounds in nanoparticulate form
AU2008217586A1 (en)	2007-02-19	2008-08-28	Cipla Limited	Pharmaceutical combinations of at least two bronchodilators or of a bronchodilator with a corticosteroid
EP2100599A1 (en)	2008-03-13	2009-09-16	Laboratorios Almirall, S.A.	Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
TWI792140B (en)	2009-05-29	2023-02-11	美商沛爾醫療股份有限公司	Compositions, methods and systems for respiratory delivery of two or more active agents
EP2510928A1 (en)	2011-04-15	2012-10-17	Almirall, S.A.	Aclidinium for use in improving the quality of sleep in respiratory patients
EP2782584B1 (en)	2011-11-23	2021-06-09	TherapeuticsMD, Inc.	Natural combination hormone replacement formulations and therapies
CN104703584B (en) *	2012-02-28	2019-05-31	艾塞尤提卡控股公司	Inhalable pharmaceutical composition
ITMI20130571A1 (en)	2013-04-10	2014-10-11	Zambon Spa	PHARMACEUTICAL COMPOSITION CONTAINING BUDESONIDE AND FORMOTEROL
IT202000006442A1 (en)	2020-03-27	2021-09-27	Genetic S P A	BUDESONIDE 21-PHOSPHATE SALTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SK285910B6 (en) *	1991-12-18	2007-10-04	Aktiebolaget Astra	Medical product comprising a combination of formoterol and budesonide

1996
- 1996-10-08 SE SE9603669A patent/SE9603669D0/en unknown
1997
- 1997-09-24 JP JP10517442A patent/JP2000502365A/en active Pending
- 1997-09-24 PL PL97327037A patent/PL327037A1/en unknown
- 1997-09-24 CA CA002239308A patent/CA2239308A1/en not_active Abandoned
- 1997-09-24 AU AU45782/97A patent/AU715319B2/en not_active Ceased
- 1997-09-24 BR BR9706822A patent/BR9706822A/en not_active IP Right Cessation
- 1997-09-24 HU HU9901674A patent/HUP9901674A3/en unknown
- 1997-09-24 NZ NZ330482A patent/NZ330482A/en unknown
- 1997-09-24 KR KR1019980704266A patent/KR19990071975A/en not_active Withdrawn
- 1997-09-24 WO PCT/SE1997/001606 patent/WO1998015280A1/en not_active Ceased
- 1997-09-24 SK SK751-98A patent/SK75198A3/en unknown
- 1997-09-24 CZ CZ981761A patent/CZ176198A3/en unknown
- 1997-09-24 EP EP97944242A patent/EP0871450A1/en not_active Withdrawn
- 1997-10-02 TW TW086114371A patent/TW470647B/en not_active IP Right Cessation
- 1997-10-03 ZA ZA9708889A patent/ZA978889B/en unknown
- 1997-10-07 AR ARP970104615A patent/AR013614A1/en not_active Application Discontinuation
- 1997-10-07 MY MYPI97004698A patent/MY128337A/en unknown
1998
- 1998-05-27 NO NO982414A patent/NO982414D0/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
KR19990071975A (en)	1999-09-27
SK75198A3 (en)	1998-11-04
AU715319B2 (en)	2000-01-20
NO982414L (en)	1998-05-27
AR013614A1 (en)	2001-01-10
CA2239308A1 (en)	1998-04-16
HUP9901674A2 (en)	1999-09-28
NZ330482A (en)	1999-11-29
TW470647B (en)	2002-01-01
ZA978889B (en)	1998-04-08
NO982414D0 (en)	1998-05-27
WO1998015280A1 (en)	1998-04-16
CZ176198A3 (en)	1998-09-16
BR9706822A (en)	1999-03-23
HUP9901674A3 (en)	2001-04-28
JP2000502365A (en)	2000-02-29
SE9603669D0 (en)	1996-10-08
MY128337A (en)	2007-01-31
EP0871450A1 (en)	1998-10-21
AU4578297A (en)	1998-05-05

Publication	Publication Date	Title
DE69722940D1 (en)	2003-07-24	Intravaskuläre prothese
DE59704951D1 (en)	2001-11-22	Plättchenförmiges titandioxidpigment
DE69715838D1 (en)	2002-10-31	Thermomorphe drucksensitive klebmittel
DE69608577D1 (en)	2000-06-29	Thermostabiler schalldämmstoff
DE69711882D1 (en)	2002-05-16	Carbolinderivate
DE69705420D1 (en)	2001-08-02	Polyurethanhartschäume
SG60040A1 (en)	1999-02-22	Novel heterroaryl-oxazolidinones
PL327037A1 (en)	1998-11-09	Novel combination
DE59705192D1 (en)	2001-12-06	Lcp-blends
DE69718335D1 (en)	2003-02-13	Sms-alarm
DE69719214D1 (en)	2003-03-27	Diamantfilmdepositionsmethode
DE59711450D1 (en)	2004-04-29	Arylalkanoylpyridazine
DE69621466D1 (en)	2002-07-04	Thermoplastische hydroxy-phenoxyetherpolymerverbundwerkstoffe
DE69703480D1 (en)	2000-12-14	Anionische photokatalysator
DE59700372D1 (en)	1999-09-30	Blockcopolymere
DE69719544D1 (en)	2003-04-10	Pyrazolderivate
DE69710573D1 (en)	2002-03-28	Morpholinyl-anthracyclinderivate
DE69720038D1 (en)	2003-04-24	Aminopyrazolderivate
DE69724432D1 (en)	2003-10-02	Polymerisationsinhibitor
DE59707730D1 (en)	2002-08-22	Peripheralpumpe
DE59703905D1 (en)	2001-08-02	Linearmotorgetriebene transportanlage
AU131131S (en)	1997-09-12	Handleset
DE69722552D1 (en)	2003-07-10	Photolithographisches gerät
PL332732A1 (en)	1999-10-11	Combination toy-candy
DE69724744D1 (en)	2003-10-16	Reversibles optisches informationsmedium